Harvard Apparatus Regenerative Technology, Inc. financial data

Symbol
HRGN on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
84 October Hill Road, Suite 11, Holliston, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Biostage, Inc. (to 7/10/2023)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 93.5 % -55.9%
Quick Ratio 4.14 %
Debt-to-equity 75.6 %
Return On Equity -612 % +59.9%
Return On Assets -272 % -28.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.9M shares +14.1%
Common Stock, Shares, Outstanding 15.9M shares +14.7%
Entity Public Float 33.8M USD -2.03%
Common Stock, Value, Issued 159K USD +14.4%
Weighted Average Number of Shares Outstanding, Basic 15M shares +8.18%
Weighted Average Number of Shares Outstanding, Diluted 15M shares +8.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Revenue from Contract with Customer, Excluding Assessed Tax 59K USD +47.5%
Research and Development Expense 2.69M USD -14.9%
Selling and Marketing Expense 143K USD 0%
General and Administrative Expense 5.08M USD -1.8%
Operating Income (Loss) -8.19M USD +5.38%
Nonoperating Income (Expense) 45K USD -43.8%
Net Income (Loss) Attributable to Parent -8.21M USD +4.64%
Earnings Per Share, Basic -0.57 USD/shares +16.2%
Earnings Per Share, Diluted -0.57 USD/shares +16.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.59M USD +1236%
Cash, Cash Equivalents, and Short-term Investments 3.6M USD +140%
Accounts Receivable, after Allowance for Credit Loss, Current 1K USD -66.7%
Inventory, Net 113K USD +102%
Other Assets, Current 51K USD +325%
Assets, Current 3.97M USD +110%
Property, Plant and Equipment, Net 13K USD -58.1%
Operating Lease, Right-of-Use Asset 318K USD +864%
Other Assets, Noncurrent 62K USD -64.2%
Assets 5.31M USD +40.4%
Accounts Payable, Current 507K USD +19.6%
Employee-related Liabilities, Current 110K USD 0%
Liabilities, Current 1.25M USD +18.2%
Operating Lease, Liability, Noncurrent 224K USD +1936%
Liabilities 1.47M USD +38%
Accumulated Other Comprehensive Income (Loss), Net of Tax -24K USD
Retained Earnings (Accumulated Deficit) -98.3M USD -9.11%
Stockholders' Equity Attributable to Parent 3.84M USD +41.4%
Liabilities and Equity 5.31M USD +40.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -960K USD +5.23%
Net Cash Provided by (Used in) Financing Activities 801K USD -73.7%
Net Cash Provided by (Used in) Investing Activities -9K USD
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 15.9M shares +14.7%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.03M USD -20%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 432K USD -65.2%
Deferred Tax Assets, Valuation Allowance 23M USD -0.77%
Deferred Tax Assets, Gross 23M USD -0.88%
Operating Lease, Liability 329K USD +270%
Depreciation 6K USD -50%
Payments to Acquire Property, Plant, and Equipment 9K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.86M USD -15.3%
Lessee, Operating Lease, Liability, to be Paid 397K USD +271%
Property, Plant and Equipment, Gross 1.49M USD +0.75%
Operating Lease, Liability, Current 105K USD +14.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 133K USD +2560%
Lessee, Operating Lease, Liability, to be Paid, Year One 129K USD +87%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 68K USD +1600%
Lessee, Operating Lease, Liability, to be Paid, Year Three 90K USD
Deferred Tax Assets, Operating Loss Carryforwards 19.2M USD -6.44%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 27K USD -10%
Additional Paid in Capital 102M USD +10.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 13K USD -67.5%
Share-based Payment Arrangement, Expense 562K USD +5.05%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares